Abnormal behaviour and Hypernatraemia

Summary:

Hypernatraemia is found among people with Abnormal behaviour, especially for people who are male, 60+ old.

The study analyzes which people have Hypernatraemia with Abnormal behaviour. It is created by eHealthMe based on reports of 10 people who have Abnormal behaviour from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Abnormal behaviour?

Abnormal behaviour is found to be associated with 1,900 drugs and 2,151 conditions by eHealthMe. Check the latest studies of Abnormal behaviour.

What is Hypernatraemia?

Hypernatraemia (an abnormally high plasma concentration of sodium ions) is found to be associated with 725 drugs and 798 conditions by eHealthMe. Check the latest studies of Hypernatraemia.



On Oct, 25, 2025

10 people who have Abnormal Behaviour and Hypernatraemia are studied.

Would you have Hypernatraemia when you have Abnormal behaviour?

Gender of people who have Abnormal Behaviour and experienced Hypernatraemia *:

  • female: 40 %
  • male: 60 %

Age of people who have Abnormal Behaviour and experienced Hypernatraemia *:

  • 0-1: 0.0 %
  • 2-9: 10 %
  • 10-19: 0.0 %
  • 20-29: 10 %
  • 30-39: 0.0 %
  • 40-49: 10 %
  • 50-59: 0.0 %
  • 60+: 70 %

Common co-existing conditions for these people *:

  1. Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 3 people, 30.00%
  2. Stress And Anxiety: 2 people, 20.00%
  3. High Blood Pressure: 2 people, 20.00%
  4. High Blood Cholesterol: 2 people, 20.00%
  5. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 2 people, 20.00%
  6. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 1 person, 10.00%
  7. Precocious Puberty: 1 person, 10.00%
  8. Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur): 1 person, 10.00%
  9. Pain: 1 person, 10.00%
  10. Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 1 person, 10.00%

Common drugs taken by these people *:

  1. Risperdal: 4 people, 40.00%
  2. Flagyl: 3 people, 30.00%
  3. Zyprexa: 2 people, 20.00%
  4. Tegretol: 2 people, 20.00%
  5. Plavix: 2 people, 20.00%
  6. Depakote: 2 people, 20.00%
  7. Levofloxacin: 2 people, 20.00%
  8. Rocephin: 2 people, 20.00%
  9. Seroquel: 2 people, 20.00%
  10. Perindopril Erbumine: 2 people, 20.00%

Common symptoms for these people *:

  1. Dehydration (dryness resulting from the removal of water): 7 people, 70.00%
  2. Acute Kidney Failure: 5 people, 50.00%
  3. Drowsiness: 5 people, 50.00%
  4. Fever: 3 people, 30.00%
  5. Agitation (state of anxiety or nervous excitement): 3 people, 30.00%
  6. Consciousness - Decreased: 2 people, 20.00%
  7. Fall: 2 people, 20.00%
  8. Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 2 people, 20.00%
  9. Miosis (constriction of the pupil of the eye, resulting from a normal response to an increase in light): 2 people, 20.00%
  10. Photophobia (extreme sensitivity to light): 2 people, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Hypernatraemia?

Check whether Hypernatraemia is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Hypernatraemia:

All the conditions that are associated with Hypernatraemia:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Hypernatraemia and Abnormal behaviour, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: